Galeterone - PDFSEARCH.IO - Document Search Engine

Galeterone
Results: 13

#	Item
1	Microsoft WordDOCX Add to Reading List Source URL: securities.stanford.edu Language: English - Date: 2016-08-03 18:48:38 Antiandrogens Chemistry Clinical medicine Enzyme inhibitors Cancer Prostate cancer Organofluorides Galeterone Steroids Enzalutamide Abiraterone acetate Medivation
2	Award ID: CP130020 Project Title: Androgen Receptor N-Terminus Blocker Program for Prostate Cancer Award Mechanism: Company Relocation Add to Reading List Source URL: www.cprit.state.tx.us Language: English - Date: 2015-03-24 12:30:06 Prostate cancer Organofluorides Prostate Androgen receptor MDV3100 Galeterone Anatomy Biology Medicine
3	September 10, 2012 Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq: Add to Reading List Source URL: astx.com Language: English Antiandrogens Oncology Prostate cancer Biology Hsp90 Heat shock protein Cancer research Galeterone Medicine Pyridines Abiraterone
4	Microsoft PowerPointGU Disease Site Schema Flowsheet.pptx Add to Reading List Source URL: www.ucdenver.edu Language: English - Date: 2015-04-07 12:33:12 Prostate cancer Abiraterone Prostate Galeterone Cabazitaxel Orteronel Anatomy Medicine Biology
5	R&D Pipeline (October[removed]Global Development (1) Approval / Labeling Revision #Compounds with "In-house" in this column include one discovered by collaborative research. (The same applicable hereafter.) Code No. Gen Add to Reading List Source URL: www.astellas.com Language: English - Date: 2014-10-30 05:54:55 Nitriles Organofluorides Prostate cancer Ribbon symbolism MDV3100 Degarelix Breast cancer Erlotinib Galeterone Chemistry Organic chemistry Medicine
6	NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals to Present at the 34th Annual Cowen Health Care Conference CAMBRIDGE, Mass., February 24, 2014 – Tokai Pharmaceuticals, Inc., a Add to Reading List Source URL: www.tokaipharma.com Language: English - Date: 2014-02-24 08:43:32 Galeterone Prostate cancer
7	NEWS RELEASE FOR IMMEDIATE RELEASE New Phase 2 Clinical Data on Tokai Pharmaceuticals’ Galeterone in Advanced Prostate Cancer to be Presented at 2014 ASCO GU Symposium CAMBRIDGE, Mass., January 9, 2014 – Tokai Pharm Add to Reading List Source URL: www.tokaipharma.com Language: English - Date: 2014-01-09 09:29:29 Galeterone Prostate cancer Oncologists Antiandrogens Testosterone Nicholas J. Vogelzang Abiraterone Medicine Endocrine system Oncology
8	NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals Appoints Karen J. Ferrante, M.D. as Head of R&D and Chief Medical Officer CAMBRIDGE, Mass., April 15, 2014 – Tokai Pharmaceuticals, Inc., a biopharmaceutical Add to Reading List Source URL: www.tokaipharma.com Language: English - Date: 2014-04-15 10:19:58 Takeda Pharmaceutical Company Millennium Pharmaceuticals Oncologists Nicholas J. Vogelzang Medicine Galeterone Prostate cancer
9	NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals Appoints John McBride as Chief Operating Officer CAMBRIDGE, Mass., February 11, 2014 – Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on devel Add to Reading List Source URL: www.tokaipharma.com Language: English - Date: 2014-02-11 08:59:12 Medicine Galeterone Prostate cancer
10	NEWS RELEASE FOR IMMEDIATE RELEASE Tokai Pharmaceuticals’ Reformulated Galeterone Demonstrates Robust PSA Reductions in Advanced Prostate Cancer Patients Interim Results from ARMOR2 Phase 2 Study Presented at 2014 ASC Add to Reading List Source URL: www.tokaipharma.com Language: English - Date: 2014-01-29 10:23:05 Prostate cancer Galeterone Abiraterone Oncologists Lactams Organofluorides Alpharadin William K. Oh Medicine Oncology Antiandrogens

UPDATE